A Methadone Maintenance Treatment Outcome Study in Three Provinces in China

NCT ID: NCT01315054

Last Updated: 2024-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

4258 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary goal of this PHE is to determine the effectiveness of a tailored education program for MMT service providers. It was to be evaluated through methadone dose levels prescribed to new patients after training completion. The effects of methadone dose, with and without the inclusion of additional counseling services, would be measured through MMT retention and illicit opioid use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methadone treatment has became one of main actions taken in China to control the spread of HIV among drug users. However,the average methadone dose used is relatively low. An intensive methadone maintenance treatment (MMT) provider training on methadone dosage may be effective in increasing the methadone dose levels prescribed to new patients. The study will evaluate the effectiveness of a tailored education program for MMT service providers using subsequent methadone dose prescribed to new patients. The effects of methadone dose, with and without the inclusion of additional psychosocial services, will then be measured through MMT retention and illicit opioid use.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Hepatitis C Syphilis Herpes Simplex Type II

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control arm

Using currently practiced methadone dosage prescription methods

Group Type OTHER

national guidelines

Intervention Type OTHER

Provided a hard copy of the existing national guidelines for methadone dosing

MMT provider dosage training

Intensive health care provider training on prescribing methadone dosage based on national guidelines

Group Type EXPERIMENTAL

MMT provider dosage training

Intervention Type BEHAVIORAL

Training on methadone dosing provided to health care providers working in methadone maintenance clinics

national guidelines

Intervention Type OTHER

Provided a hard copy of the existing national guidelines for methadone dosing

MMT provider dosage training/counseling

Intensive health care provider training on prescribing methadone dosage, plus providing on-site psychosocial counseling services and peer support to clients .

Group Type EXPERIMENTAL

MMT provider dosage training

Intervention Type BEHAVIORAL

Training on methadone dosing provided to health care providers working in methadone maintenance clinics

targeted counseling

Intervention Type BEHAVIORAL

targeted counseling provided to methadone maintenance clinic attendees

national guidelines

Intervention Type OTHER

Provided a hard copy of the existing national guidelines for methadone dosing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MMT provider dosage training

Training on methadone dosing provided to health care providers working in methadone maintenance clinics

Intervention Type BEHAVIORAL

targeted counseling

targeted counseling provided to methadone maintenance clinic attendees

Intervention Type BEHAVIORAL

national guidelines

Provided a hard copy of the existing national guidelines for methadone dosing

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

training counseling dosing guidelines

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* client participants will include both men and women who are opiate-dependent drug users who started MMT not more than one month prior to enrollment in the study
* 18 years of age or older
* residing in the study areas
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center for AIDS/STD Control and Prevention, China CDC

OTHER_GOV

Sponsor Role collaborator

Centers for Disease Control and Prevention

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marc Bulterys, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

US CDC GAP China

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Center for HIV/STD Prevention and Control, China CDC

Beijing, , China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CN_09_217

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

CDC-CGH-6014

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Methadone Maintenance for Prisoners
NCT00378079 COMPLETED PHASE3